Inspecs Group Plc (GB:SPEC)
LSE:SPEC
Want to see GB:SPEC full AI Analyst Report?
Top Page
Inspecs Group Plc
(LSE:SPEC)
Select Model
Select Model
Rating:49Neutral
Price Target:
100.00 p
▲(41.24% Upside)
Action:Reiterated
Date:05/21/26
The score is primarily held back by weak financial performance—ongoing net losses, a sharp 2025 revenue decline, and a recent swing to negative free cash flow. Technicals are moderately supportive with price above longer-term moving averages and mildly positive momentum, but valuation metrics provide limited support given the loss-making profile and no stated dividend yield.
Positive Factors
Multi-brand, multi-channel distribution
The group combines proprietary and licensed brands with in-house design and third-party manufacturing plus multi-country wholesale distribution to opticians and retailers. This diversified, capital-light model supports scalable reach, reduces single-customer risk and underpins durable revenue channels.
Negative Factors
Persistent net losses
Consistent net losses limit retained earnings and internal capital generation, depressing ROE and forcing reliance on external financing or cost restructuring. If sustained, this undermines the firm's ability to invest in growth, maintain licenses, and return capital to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-brand, multi-channel distribution
The group combines proprietary and licensed brands with in-house design and third-party manufacturing plus multi-country wholesale distribution to opticians and retailers. This diversified, capital-light model supports scalable reach, reduces single-customer risk and underpins durable revenue channels.
Read all positive factors
Inspecs Group Plc (SPEC) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£109.72M
Dividend YieldN/A
Average Volume (3M)117.09K
Price to Earnings (P/E)―
Beta (1Y)0.44
Revenue Growth-3.31%
EPS Growth-107.51%
CountryUK
Employees1,654
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)-0.07
Shares Outstanding109,174,520
10 Day Avg. Volume109,092
30 Day Avg. Volume117,088
Financial Highlights & Ratios
PEG Ratio-0.36
Price to Book (P/B)1.23
Price to Sales (P/S)0.51
P/FCF Ratio-43.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)£196.00M
Inspecs Group Plc Business Overview & Revenue Model
Company Description
INSPECS Group plc is an enterprise specializing in the full lifecycle of eyewear, from initial design and production to marketing, sales, and distribution. Their offerings encompass stylish glasses for both fashion and as original equipment manufa...
How the Company Makes Money
Inspecs Group makes money primarily by selling eyewear products—optical frames and sunglasses—through wholesale distribution to business customers (e.g., opticians and eyewear retailers). Revenue is generated from (1) sales of products under the c...
Inspecs Group Plc Financial Statement Overview
Summary
Income Statement
38
Negative
Balance Sheet
57
Neutral
Cash Flow
31
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 191.70M | 198.26M | 203.29M | 200.96M | 182.62M |
| Gross Profit | 87.37M | 103.45M | 103.55M | 98.86M | 85.78M |
| EBITDA | 17.49M | 15.75M | 17.27M | 8.28M | 6.05M |
| Net Income | -6.51M | -4.61M | -997.00K | -6.32M | ― |
Balance Sheet | |||||
| Total Assets | 202.23M | 220.25M | 221.91M | 292.68M | 326.36M |
| Cash, Cash Equivalents and Short-Term Investments | 15.99M | 23.96M | 20.07M | 26.80M | 29.76M |
| Total Debt | 59.78M | 62.47M | 62.12M | 69.78M | 69.44M |
| Total Liabilities | 122.51M | 121.56M | 118.39M | 162.59M | 181.13M |
| Stockholders Equity | 79.72M | 98.69M | 103.52M | 130.09M | 145.22M |
Cash Flow | |||||
| Free Cash Flow | -2.26M | 4.28M | 6.92M | 842.00K | 12.37M |
| Operating Cash Flow | 93.00K | 7.20M | 12.66M | 5.08M | 19.75M |
| Investing Cash Flow | -2.65M | -2.52M | -6.18M | -4.19M | -15.66M |
| Financing Cash Flow | -4.85M | -426.00K | -8.84M | -4.40M | 1.26M |
Inspecs Group Plc Technical Analysis
Positive
70.80
Price Trends
84.69
Positive
81.94
Positive
71.26
Positive
Market Momentum
3.08
Negative
99.40
Negative
83.83
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:SPEC, the sentiment is Positive. The current price of 70.8 is below the 20-day moving average (MA) of 86.50, below the 50-day MA of 84.69, and below the 200-day MA of 71.26, indicating a bullish trend. The MACD of 3.08 indicates Negative momentum. The RSI at 99.40 is Negative, neither overbought nor oversold. The STOCH value of 83.83 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:SPEC.
Inspecs Group Plc Peers Comparison
UnderperformOutperform
Sector (51)
GB:SPEC
Inspecs Group Plc
100.50
52.00
107.22%
GB:CVSG
CVS Group plc
1,180.00
-73.28
-5.85%
Inspecs Group Plc Corporate Events
Business Operations and StrategyPrivate Placements and Financing
Inspecs secures Qualcomm investment and smart eyewear partnership
Positive
Jun 16, 2026
Inspecs Group has secured a $10m (£7.5m) strategic equity investment from Qualcomm Technologies via a subscription for 7.5m new shares at £1 each, with the funds earmarked to support growth and general working capital. The move modestly ...
Financial DisclosuresRegulatory Filings and ComplianceShareholder Meetings
Inspecs Publishes Annual Report and Sets Date for 2026 AGM
Neutral
Jun 8, 2026
Inspecs Group plc has posted its latest Annual Report and Accounts and the notice of its upcoming Annual General Meeting, making these documents available to shareholders on its website. The AGM is scheduled to take place on 30 June 2026 at 11:00 ...
Business Operations and StrategyExecutive/Board ChangesRegulatory Filings and Compliance
Inspecs strengthens Bidco influence with Luke Johnson board appointment
Neutral
May 19, 2026
Inspecs Group has reshaped its board following the recent takeover offer by Bidco 1125 Limited, appointing Luke Johnson as a non-executive director and naming Ian Livingstone as a non-voting board observer representing Bidco’s majority inter...
Business Operations and StrategyExecutive/Board Changes
Inspecs Founder to Reassume Executive Chair Role as Interim Chair Departs
Positive
May 18, 2026
Inspecs Group plc, a leading global eyewear provider, produces branded and OEM frames, sunglasses, safety eyewear and low vision aids for retailers and opticians in more than 80 countries. Its vertically integrated model, expanding manufacturing f...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Inspecs holds revenue steady, streamlines operations as takeover turns unconditional
Neutral
May 13, 2026
Inspecs Group reported 2025 revenue of £191.7m, broadly flat year on year on a constant‑currency basis, with gross margin slipping to 51.7% and underlying EBITDA down to £17.7m amid U.S. tariff pressure and a tough consumer backdro...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.